th<\/sup> Conference of the Parties to the Convention on Biological Diversity. We will be supporting ambitious targets to bend the curve on biodiversity loss by 2030 - including in areas which will help to recover insect populations, such as ecosystem restoration and species recovery - supported by strengthened reporting and review mechanisms to help facilitate the implementation of the targets.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4062", "label" : {"_value" : "Biography information for Lord Goldsmith of Richmond Park"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Goldsmith of Richmond Park"}
, "dateOfAnswer" : {"_value" : "2021-05-25", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-05-25T11:25:28.74Z", "_datatype" : "dateTime"}
]}
, "hansardHeading" : {"_value" : "Insects: EU Countries"}
, "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion"}
, {"_about" : "http://data.parliament.uk/resources/1313660", "answer" : {"_about" : "http://data.parliament.uk/resources/1313660/answer", "answerText" : {"_value" : "The tax treaty between the UK and Canada does not override the provision of UK law that treats members of the House of Commons and House of Lords as domiciled in the UK for tax purposes.<\/p>
<\/p>
UK law also treats members of the House of Commons and House of Lords as resident in the UK for tax purposes. Where an MP or peer was also resident in Canada for tax purposes under Canadian law, a tie-breaker in the tax treaty would determine the state in which the member was considered to be resident for the purposes of applying the tax treaty.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4689", "label" : {"_value" : "Biography information for Lord Agnew of Oulton"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Agnew of Oulton"}
, "dateOfAnswer" : {"_value" : "2021-05-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-05-20T14:26:15.317Z", "_datatype" : "dateTime"}
]}
, "hansardHeading" : {"_value" : "Taxation: Treaties"}
, "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion"}
, {"_about" : "http://data.parliament.uk/resources/100020", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100020/answer", "answerText" : {"_value" : "
The Prime Minister\u2019s £50 million Challenge Fund is currently improving general practitioner access for over two million patients across England. This includes offering evening and weekend appointments, as well as better use of technology, such as telehealth, to look after patients. By January, 7.5 million patients will be covered.<\/p>
<\/p>
<\/p>
<\/p>
And, we have recently announced another £100 million of funding for next year to improve access for even more patients.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-21T15:48:51.1448684Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Practitioners: Standards"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what progress has been made on improving access to GPs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4081", "label" : {"_value" : "Biography information for Lord Evans of Rainow"}
}
, "tablingMemberConstituency" : {"_value" : "Weaver Vale"}
, "tablingMemberPrinted" : [{"_value" : "Graham Evans"}
], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "905556"}
, {"_about" : "http://data.parliament.uk/resources/100021", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100021/answer", "answerText" : {"_value" : "
Adults with care and support needs should be able to move between countries within the United Kingdom knowing that their care will continue during the move.<\/p>
<\/p>
<\/p>
<\/p>
As the care and support systems in the four countries are different, we are developing principles with the Devolved Administrations to ensure continuity of care for people moving.<\/p>
<\/p>
These should be published in November.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "answeringMemberConstituency" : {"_value" : "North Norfolk"}
, "answeringMemberPrinted" : {"_value" : "Norman Lamb"}
, "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-21T15:45:44.866352Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Home Care Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, if he will bring forward proposals to facilitate the portability of home-based care packages between local authorities in different countries in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3965", "label" : {"_value" : "Biography information for Sheila Gilmore"}
}
, "tablingMemberConstituency" : {"_value" : "Edinburgh East"}
, "tablingMemberPrinted" : [{"_value" : "Sheila Gilmore"}
], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "905560"}
, {"_about" : "http://data.parliament.uk/resources/100022", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100022/answer", "answerText" : {"_value" : "
We are committed to patients having greater choice and control over their healthcare, as this can help drive up standards and improve patient care.<\/p>
<\/p>
<\/p>
<\/p>
We believe that patient empowerment is vital to the National Health Service in the 21st century. This Government is committed to continuing to develop digital platforms to enable this to happen, such as My NHS and the NHS e-Referral Service.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-21T16:00:56.1397924Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Patient Choice Schemes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to promote patient choice.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4104", "label" : {"_value" : "Biography information for Neil Carmichael"}
}
, "tablingMemberConstituency" : {"_value" : "Stroud"}
, "tablingMemberPrinted" : [{"_value" : "Neil Carmichael"}
], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "905559"}
, {"_about" : "http://data.parliament.uk/resources/1000220", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1000220/answer", "answerText" : {"_value" : "
The detail of the UK\u2019s association to the EU Registration, Evaluation, Authorisation & restriction of Chemicals programme after the UK leaves the EU is part of ongoing negotiations. The UK and the EU have a mutual interest in maintaining our integrated chemical supply chains as the chemicals industry is an economically significant sector in both regions, and it underpins key downstream sectors including automotive, aerospace, construction and pharmaceuticals. In the White Paper on our future relationship with the European Union published in July, the UK has proposed that chemicals are part of a UK-EU free trade area on goods, with continued UK participation in the European Chemicals Agency (ECHA) underpinning this arrangement. This proposal is part of ongoing negotiation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4068", "label" : {"_value" : "Biography information for Lord Harrington of Watford"}
}
, "answeringMemberConstituency" : {"_value" : "Watford"}
, "answeringMemberPrinted" : {"_value" : "Richard Harrington"}
, "dateOfAnswer" : {"_value" : "2018-11-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-09T14:57:52.953Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2018-11-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Chemicals: EU Law"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate he has made of any potential increase in red tape from the proposed associate status of the EU Registration, Evaluation, Authorisation & restriction of Chemicals programme after the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4006", "label" : {"_value" : "Biography information for Dr Matthew Offord"}
}
, "tablingMemberConstituency" : {"_value" : "Hendon"}
, "tablingMemberPrinted" : [{"_value" : "Dr Matthew Offord"}
], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "187324"}
, {"_about" : "http://data.parliament.uk/resources/1000221", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1000221/answer", "answerText" : {"_value" : "
As far as we are aware no US sanctions are being considered against the Leader of the Opposition.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/343", "label" : {"_value" : "Biography information for Sir Alan Duncan"}
}
, "answeringMemberConstituency" : {"_value" : "Rutland and Melton"}
, "answeringMemberPrinted" : {"_value" : "Sir Alan Duncan"}
, "dateOfAnswer" : {"_value" : "2018-11-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-12T14:46:40.933Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "16"}
, "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"}
, "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"}
, "date" : {"_value" : "2018-11-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Jeremy Corbyn"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, what assessment his Department has made of the potential implications for democracy in the UK of the US imposing sanctions on the official leader of the UK opposition.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4006", "label" : {"_value" : "Biography information for Dr Matthew Offord"}
}
, "tablingMemberConstituency" : {"_value" : "Hendon"}
, "tablingMemberPrinted" : [{"_value" : "Dr Matthew Offord"}
], "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "187325"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=2&_view=AnsweredQuestions&_properties=type.&_sort=legislature.prefLabel,type,-type.", "page" : 1, "prev" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&_view=AnsweredQuestions&_properties=type.&_sort=legislature.prefLabel,type,-type.", "startIndex" : 11, "totalResults" : 546209, "type" : "http://purl.org/linked-data/api/vocab#Page"}
}